ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $52,346 | 0.0% | 11,581 | 0.0% | 0.00% | – |
| Q1 2023 | $52,346 | -100.0% | 11,581 | -12.6% | 0.00% | – |
| Q2 2022 | $107,201,000 | -98.3% | 13,251 | -96.4% | 0.00% | -100.0% |
| Q1 2022 | $6,179,535,000 | -18.4% | 365,653 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $7,569,895,000 | -62.4% | 352,252 | +29.3% | 0.00% | -62.5% |
| Q3 2021 | $20,114,811,000 | +33.2% | 272,337 | -1.4% | 0.01% | +33.3% |
| Q2 2021 | $15,098,952,000 | +12.0% | 276,133 | +51.0% | 0.01% | 0.0% |
| Q1 2021 | $13,484,096,000 | +371.0% | 182,860 | +450.6% | 0.01% | +500.0% |
| Q4 2020 | $2,862,616,000 | – | 33,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |